BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

4 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase.EBI
Agrevo
Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.EBI
TBA
AMP deaminase inhibitors. 2. Initial discovery of a non-nucleotide transition-state inhibitor series.EBI
Metabasis Therapeutics
Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.BDB
Astrazeneca R&D